News

Precision oncology news and market access analysis on diagnostics, liquid biopsy, MRD testing and European healthcare systems.

Laboratory scientist analysing genomic sequencing data, representing the Hologic HER2DX acquisition reshaping breast cancer testing access in Europe

Hologic HER2DX acquisition

05/11/2026

A stool-based diagnostic test kit beside a European Union flag, representing new access to colorectal cancer screening in Europe following CE marking under the IVDR

Colorectal Cancer Screening Europe

28/10/2026

Illustration representing blood-based colorectal cancer screening, AI-powered digital pathology, and the regulatory pathway to European diagnostic market access

Blood-Based Colorectal Cancer Screening

21/10/2026